Trials / Completed
CompletedNCT05223907
Safety and Efficacy of Maintenance of Etomidate in General Anesthesia
Safety and Efficacy of Maintenance of Etomidate Combined With Sevoflurane in General Anesthesia: a Multi-center Randomized Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,080 (actual)
- Sponsor
- Henan Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to use etomidate combined with sevoflurane intravenously to maintain anesthesia process under the monitoring of BIS. Propofol was used as the controls. Blood pressure and heart rate were recorded during operation. The VAS pain score was observed after surgery.To investigate whether this program can better maintain intraoperative hemodynamic stability, improve the quality of recovery, and reduce the incidence of postoperative adverse reactions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etomidate | Etomidate will be used for general anesthesia |
| DRUG | Propofol | Propofol will be used for general anesthesia |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2022-02-04
- Last updated
- 2024-06-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05223907. Inclusion in this directory is not an endorsement.